IL10 and malaria: Inhibiting IFN-γ and increasing IL-10, an attempt to balance anti-inflammatory and pro-inflammatory cytokines, seem fundamental to controlling parasitemia, symptoms, and severity of malaria (Farrington et al., 2017; Kumar et al., 2019).